DOSAGE AND ADMINISTRATION
The recommended dosage is one drop in the affected eye(s) once-daily in the evening. The dosage of TRAVATAN® Solution should not exceed once-daily since it has been shown that more frequent administration may decrease the intraocular pressure lowering effect.
Reduction of intraocular pressure starts approximately 2 hours after administration and the maximum effect is reached after 12 hours.
TRAVATAN® Solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.
|
HOW SUPPLIED
TRAVATAN® (travoprost ophthalmic solution) 0.004% is a sterile, isotonic, buffered, preserved, aqueous solution of travoprost (0.04 mg/mL) supplied in Alcon’s oval DROP-TAINER® package system.
TRAVATAN® Solution is supplied as a 2.5 mL solution in a 4 mL and a 5 mL solution in a 7.5 mL natural polypropylene dispenser bottle with a natural polypropylene dropper tip and a turquoise polypropylene overcap. Tamper evidence is provided with a shrink band around the closure and neck area of the package.
NDC 0065-0266-25, 2.5 mL fill
NDC 0065-0266-17, 2 units, 2.5 mL fill each
NDC 0065-0266-34, 5 mL fill
Storage
Store at 2º- 25ºC (36º - 77ºF).
Rx Only
U.S. Patent Nos. 5,631,287; 5,849,792; 5,889,052; 6,011,062 and 6,235,781.
* TIMOPTIC is a registered trademark of Merck & Co., Inc.
ALCON LABORATORIES, INC.
Fort Worth, Texas 76134 USA
345308-0604
|